Effect of fermented camel milk and cow milk containing

2 downloads 0 Views 100KB Size Report
C+Bnb-12. Fermented cow milk basl diet =cholesterol-free diet .... cholesterol level in human subjects (Buonopane, et al,. 1992) and in rats (Rao, et al, 1981).
Agricultural Science Research Journal 3(11); pp. 342- 346, November 2013 Available online at http://www.resjournals.com/ARJ ISSN: 2026 – 6332 ©2013 International Research Journals

Full Length Research Paper

Effect of fermented camel milk and cow milk containing (bifidobacteria) enriched diet in rats fed on cholesterol level *Abdelrahim A. Ali1, Abdallah A. Alyan2, Abdulaziz S. Bahobail3 1

Department of Chemistry, Faculty of Science and Education (Khurma Branch), Taif University Department of Biotechnology, Faculty of Science and Education (Khurma Branch), Taif University 3 Department of Microbiology, Faculty of Science, Taif University

2

*Corresponding Author’s Email:[email protected] Abstract The effect of fermented camel milk Gariss and fermented cow milk +Bifidobaceriaon plasma on liver lipids was determined in rats fed with cholesterol enriched diet. The two groups were decreased the levels of plasma total cholesterol, Very Low-Density Lipoprotein (VLDL) and Low-Density Lipoprotein (LDL) cholesterol than the positive control group. Gariss- was more effective in the lowering of plasma and liver cholesterol levels than fermented cow milk +Bifidobacteria. Key words: Cholesterol, fermentation, camel milk, plasma lipids.

INTRODUCTION For a long time, milk was considered to only provide nutritional components such as essential amino acids (Hambræus, 1992). In the last decades, several studies have shown that milk is an important nutritional and functional source and could provide particular health benefits due to the presence of bioactive substances in milk. Fresh and fermented Dromedary camel milk have been acknowledged for a long time in different parts of the world to provide a potential treatment for a series of diseases such as dropsy, jaundice, tuberculosis, asthma, and leishmaniasis or kala-azar (Abdelgadir et al., 1998; Shalash, 1984). These potential health benefits are obtained through a number of bioactive components in camel milk. These components were reported to exist naturally in camel milk (Agrawal et al., 2007a; El-Agamy, et al, 1992); or derived from camel milk proteins using probiotic strains (Elayan et al., 2008; Quan et al., 2008).Coronary heart disease is one of the major causes of death in the industrialized countries (Pereira & Gibson, 2002). Elevated levels of blood and dietary cholesterol are considered to be a major risk factor for coronary heart diseases (Reddy, et al, 1977).

Fermented camel milk (Gariss) and Gariss containing Bifidobacterium lactis (BB-12) administration have been reported to possess a hypocholesterolaemic effect in vivo in rats (Elayan et al 2008) This strain was previously shown to reduce cholesterol in bovine milk and MRS broth (Alhaj et al., 2006) The hypocholesterolaemic mechanism of camel milk is still unclear, but different hypotheses have been proposed including: interaction between bioactive peptides derived from camel milk proteins and cholesterol which result in cholesterol reduction (Li & Papadopoulos,1998;Seelig & Seelig,1996).Fermented dairy products have been recommended as dietary supplements because of their hypocholesterolaemic effect in humans (Mann, 1977) and rats (Suzuki et al., 1991). It was reported that buffalo milk youghurt or soyinilk yoghurt containing bifidobacterium reduced the level of plasma and liver cholesterol (Abdel Gawad et al., 1998). Therefore, the objective of this study was to detect the hypocholesterolaemic effect of Gariss and fermented cow milk containing bifidobacterium on the levels of plasma and liver lipids of rats.

343

Table 1. The experimental rats groups and their diets Diet treatment Cholesterol free diet Cholesterol – Enrich Diect(CED) CED+ Gariss fermented camel milk CED+ Fermented cow milk

Diet code Negative Control Positive control C+Bnb-12

Diet formula 100 g basal diet+50ml water 99.5g basal diect+0.5 g cholesterol+50ml water 99.5 g basal diect+0.5 g +0.5 g cholesterol+50g Gariss Fermented cow milk

basl diet =cholesterol-free diet CED =cholesterol-enriched diet

Materials and Methods

VLD+LDL cholesterol= cholesterol.

Total

cholesterol



HDL

Animal Feeding Experiment Twenty four albino rats with an average weight between 80 and 100g were house at 23±1oC and 60±5% relative humidity. All animals were fed on basal diet (cholesterolfree diet) for one week. After this adoption period, the rats were divided randomly into 4 experimental groups; one group received a basal diet throughout the experimental period for 6 weeks and served as a negative control group. The other three groups were fed on basal diet with cholesterol added at a level of 0.5% (w/w) cholesterol-enriched diet) for 1-2 weeks to create hypercholesterolaemic rats. One of the three groups, which served as positive control group, was fed only on a cholesterol enriched diet for the six-week period. The other 2 groups were fed for five weeks on a cholesterol-enriched diet supplemented with G and fermented cow milk. The experimental diet given to the 4 groups are described in Table 1. The rats were allowed free access to experimental diet and water and their body weights were monitored, at the end of the 6weeks experimental period. Blood samples were collected from the eye vein under diethyl ether anesthesia. The samples were collected in tubes, with EDTA as an anti-coagulating agent. The tubes were centrifuged at 3000 rpm for 15 min to obtain the plasma, which was kept frozen (-23+1oC) until analysis. The rats were sacrificed and the liver, heart, kidney and spleen were excised immediately and weighed. The liver was washed with ice-cold saline solution (0.9 w/v,NaCl) and stored at 23+±1oC until analyzed. The basal diet consisted of 5% (w/w), casein 10% (w/w), maize oil 10% (w/w), cellulose 4% (w/w), mineral mix 1% (w/w), vitamin mix 1% and starch 60% (w/w). Determination of Plasma Lipid Total plasma cholesterol, High Density Lipoprotein (HDL) and triglycerides determined using the enzymatic colorimetric method according to Trinder (1969). The VLD+LDL were calculated as follows:

Determination of Cholesterol and Triglycerides in Liver Cholesterol and triglycerides were extracted from the liver by the method of Fernandez et al. (1997) and were measure by the method of Trinder (1969). Statistical Analysis Dates are presented as means and standard deviations. The significance between groups/treatments was evaluated using general linear model procedure of Statistical Analysis Systems (SAS) (1990). The biological examination data was analyzed by least Significant Difference (LSD) at p < 0.05 (SAS, 1990). RESULTS AND DISCUSSION Plasma and Lipids The effect of on liver triglyceride, total cholesterol and 7 keto-cholesterol in rats fed on cholesterol enriched diets were presented in Table (2) .The total concentration of plasma cholesterol was significantly reduced from 135.7 mg/100Ml in the positive control to the mean value of 87.9mg/100Ml in both Garris and Cow-Bb-12groups. This decrease corresponds to 35.3 and 35.2% reduction, respectively. In contrast, there was no significant difference in total cholesterol detected in (Garris and Cow milk-Bb-12) and negative control groups. Anderson and Gilland (1999) found that every 1% reduction in serum cholesterol concentration is associated with an estimated 2% to 3% reduction in risk coronary heart disease, regular intake of fermented milk containing an appropriate strain of L. acidophilus has potential of reducing risk for coronary heart disease by 6 to 10%. It was noticed cholesterol-enriched diet (supplemented with Cow milk-Bb-12) lowered total cholesterol with the same efficiency of Gariss. Abdel Gawad et al. (1998)

344

reported that cholesterol –enrich diet supplemented with yoghurt containing bifidobacteria were more effective at lowering total cholesterol. Beena and Prasad (1997) found lower serum cholesterol in rats fed on yoghurt containing Bifidobacterium bifidum (120 mg/100 Ml) compared to a positive control (176 mg/100 Ml) after 30 days. However, Homma (1998) found that fermented milk containing bifidobactria (10 cfu g-1) resulted in a decrease in the total cholesterol level from 300 to 150 mg/100Ml) in human subject. Moreover, Schammrann et al. (2001) reported that the consumption of the probiotic youghurt made by B. Longum and Lactobacillus acidophihus decreased total cholesterol in hypercholesterolaemic women from 293 mg/100 Ml at the beginning of experiment to 255 mg/100ml after 153 days. Fermented camel milk (Gariss) and Gariss containing Bifidobacterium lactis (BB-12) administration have been reported to possess a hypocholesterolaemic effect in vivo in rats (Elayan et al., 2008). This strain was previously shown to reduce cholesterol in bovine milk and MRS broth (Alhaj et al., 2006) as well as in trypticase- peptone yeast extract medium (Tahri, et al, 1995). The hypocholesterolaemic mechanism of camel milk is still unclear, but different hypotheses have been proposed, including: interaction between bioactive peptides derived from camel milk proteins and cholesterol which result in cholesterol reduction (Li and Papadopoulos, 1998; Seelig and Seelig, 1996), and the presence of orotic acid in camel milk which is thought to be responsible for lowering cholesterol level in human subjects (Buonopane, et al, 1992) and in rats (Rao, et al, 1981). As shown in Table 3, there was no significant difference in the plasma HDL-cholesterol level between the negative control group and other experimental groups at the end of the 6week experimental period. Endo et al. (1999) reported that the addition of the probiotic to diect had on effect on the HDL-cholesterol level. Our data agree well with this finding. Rats fed on (Garris) and (Cow milk+Bb-12) diet significantly lowered plasma VLDL+LDL-cholesterol than positive control group of rats. The G diets more effective in lowering plasma VLDL+LDL-cholesterol levels than (Cow milk+Bb-12) .Beena and Prasad (1997) found that yoghurt containing B. bifidum markedly lowered the levels of LDL-cholesterol in rats fed on a cholesterol-enriched diet (positive control) from 97mg/100 mL to 22.16 and 15mg/100ml respectively, in rats fed on yoghurt containing B. bifidum fortified with skimmed milk, condensed whey or lactose-hydrolysed condensed whey at the end of the 30 days experimental period. Moreover, Schaamann et al. (2001) reported that the consumption of probiotic yoghurt made using B. longum and L. acidophilus reduced the LDL –cholesterol level in normocholesterolaemic and cholesterolamemic women. The levels of plasma triglycerides in rats fed on (Garris) and (Cow milk+Bb-12) diets were significantly. Lower

than that in those fed the cholesterol-enriched diet (positive control). The reduction in triglyceride levels with the above mentioned groups was 52.6 and 33.1, respectively (Table 3). Schaarmann et al.(2001) reported that the consumption of probiotic yoghurt made with B. longum and L. acidphilus lowered triglycerides in hypercholesterolaemic women from 114 mg/100 Ml to 91 mg/100 Ml after 153 days. The data in Table 4 show that the content of liver cholesterol in the positive control group (4.94mg-1) was significantly higher than in the negative control group (2.38mg g-1). In addition, there was a significant difference between rats feed on the positive control diet and those fed on (Garris) and (Cow milk+Bb-12) diets. It can be observed that fermented camel milk was effective in lowering to the levels of liver cholesterol. These results are in agreement with those reported by Kheadr et al. (2000) who suggested that the yoghurt diets supplemented with B. bifidum reduced cholesterol in rat liver tissues. The content of liver triglycerides was significantly higher in rats fed on the positive control diet than those fed the negative control diet (Table 4). In contrast, the levels of liver trighycerides in rats fed on the experimental diet groups were significantly lower than in rats fed on the positive control diet. The value of body weight gain was significantly higher in rats fed (Garris) and (Cow milk+Bb12) than that in rats fed the negative control diet. The body weight gain in rats fed (Cow milk+Bb-12) diet was nonesignificantly higher than that in rat fed the positive control diet (Table 4). No significant difference in weights of heart or were detected between rats fed on the (Garris) and (Cow milk+Bb-12) diets and rats fed the two control diets. There was a significant difference in kidney weight between rats fed the negative control diet and rats fed other diets. The liver weight in rats fed the positive control diet was significantly higher than rats fed negative control diet. There was a significant difference in the liver weight between rats fed the positive control diet and rats fed the other experimental diets.

Conclusions This study has concluded that a cholesterol-enriched diet of rats containing fermented camel milk and fermented cow milk with bifidobacteria had a market effect level of plasma and liver lipids. Fermented camel milk and fermented cow milk containing bifidobacterium Bb-12 were very effective in lowering the level of plasma and liver lipids in rats. These hypecholesterolaemic effects of Gariss and fermented cow milk containing bifidobacterium Bb-12, which have been demonstrated in the rats in the present study, could make an effective and economic contribution in treating hyperchloesterolaemic if these effects could be confirmed in human volunteers.

345

Table 2. Effect of on liver triglyceride, total cholesterol and 7 keto-cholesterol in rats fed on cholesterol enriched diet

Treatments Positive control Negative control Fermented camel milk Fermented cow milk

Tryglyceride (mg g-1) 25.22±2.87 19.71±0.46 18.32± 3.90 20.16±3.07

Total cholesterol (mg g-1) 4.94±0.47 2.38±0.27 2.73±0.21 2.69±0.38

Table 3. Effect on serum lipid profile in rats fed on cholesterol enriched diet

Treatments Positive control Negative control Fermented camel milk Fermented cow milk

Triglyceride -1 (Mg 100Ml ) 144.27 ± 4.47 77.28 ± 3.64 68.25 ± 3.30 68.25 ± 3.30

Total cholesterol -1 (Mg 100Ml ) 135.79 ± 8.74 109.23 ± 5.77 87.93 ± 4.00 87.95 ± 9.48

HDL -1 (Mg 100Ml ) 11.66 ± 1.29 36.12 ± 1.88 28.78 ± 1.07 29.87 ± 1.04

VLDL+LDL -1 (Mg 100Ml ) 124.13 ± 7.55 73.10 ± 4.93 59.16 ± 2.94 58.07 ± 8.60

Table 4. Effect on bodyweight gain and weight of liver, hart and kidney in rats feed on cholesterol enriched diet Treatments Positive control Negative control Fermented camel milk Fermented cow milk

Body gain 20.5 ± 15.87 17.10 ± 12.25 25.27 ± 5.32 26.25 ± 1.69

Liver 7.68 ± 0.56 3.95 ± 0.28 6.02 ± 0.89 6.11 ± 0.26

Acknowledgments The authors want to thanks Taif University. This review forms part a research carried out at the Food research cooperation Egypt. The authors express their sincere thanks to all staff and the colleagues for their assistance. References Abdel GawadIA, AA Hefny, EM EI-Sayed, FFA Saleh (1998). Reduction of flatulence causing soy rnilk oligosaccharides by different starter cultures, In: Proceeding of the Seventh Egyptian Conference for Dairy Science @ Technology. Egyptian Society of Dairy Science: Cairo, Egypt, pp: 125-144. AbdelgadirWS, Ahmed TK, Dirar HA (1998). The traditional fermented milk products of the Sudan, International Journal of Food Microbiology, 44: 1-13 AgrawalRP, Budania S, Sharma P, Gupta R, KocharDK (2007a). Zero prevalence of diabetes in camel milk consuming Raica community of northwest Rajasthan, India. Diabetes Research and Clinical Practice, 76:290-296. AgrawalRP, SaranS, Sharma P, Gupta R, KocharDK, Sahani MS (2007b).Effect of camel milk on residual b-cell function in recent onset type 1 diabetes Diabetes Research and Clinical Practice, 77: 494-495 AlhajOA, Kanekanian A, Peters A (2006). The effect of Bifid bacterium lactis and trypsin on cholesterol International food

HEART 0.69 ± 0.05 0.42 ± 0.06 0.49 ± 0.06 0.50 ± 0.08

Kidney 1.30 ± 0.15 0.89 ± 0.01 1.18 ± 0.12 1.09 ± 0.09

and health innovation conference, Malmö, Sweden: Skåne Food Innovation Network. Anderson JW, Gilliland SE (1999). Effect of fermented milk (yogurt) containing Lactobacillus acidophilus L1 on serum cholesterol in hypercholesterolemia humans. J. Am. Coll. Nutr. 1: 43-50. BeenaA, V Prasad (1997). Effect of yoghurt and bifidus yoghurt foritified with skim milk powder, condensed whey and lactosehydrolysed condensed whey on serum cholesterol and triacylglycerol levels in rats, J.Dairy Res., 64:453-457. BuonopaneGJ, Kilara A, Smith JS, McCarthy RD (1992). Effect of skim milk supplementation on blood cholesterol concentration, blood pressure, and triglycerides in a freeliving human population, Journal of American College of Nutrition, 11: 56-67 .ElayanAA, Sulieman AE, Saleh FA (2008). The hypocholesterolemic effect of Gariss and Gariss containing Bifidobacteria in rats fed on a cholesterol-enriched diet. Asian Journal of Biochemistry, 3: 43-47. EndoT,M Nakaro, S Shimizu, MFukushima, SMiyoshi (1999).Effects of a probiotic on the lipid metabolism of cocks fed on a cholesterol-enriched diet.Biosci.Biotechnol.Biochem. 63:1569-1575 FernandezML,SVega,MTAyala, HShen, KConde,M Vergarajimenez, ARobbins (1997). VitaminClevel and dictray fat saturation alter hepatic cholesterol homeostasis and plasma LDL metabolism in Guines pigs. Nutr.Biochem., 8:414-424. HaheadrEE,AMAbd El-Rahman, FAHAbd El-Soukkary (2000).Impact of yoghurt and probiotic strains on serum

346

cholesterol and lipoprotein profile in rats,Alexandaria J.Agric.Res., 45:81-100. HambræusL (1992). Nutritional aspects of milk proteins, In P. F. Fox (Ed.), advanced dairy chemistry. Proteins, Vol. 1 (2nd ed.) (pp. 57e490). London, UK: Elsevier Applied Science. HommaN (1998).Bifdobacteria as a resistance factor in human beings, Bifidobacteria Micoflaora,7:35-43. Li H, Papadopoulos V (1998). Peripheral-type benzodiazepine receptor function in cholesterol transport. Identification of a putative cholesterol recognition/ interaction amino acid sequence and consensus pattern, Endocrinology, 139: 49914997. MannGV (1977). A factor in yoghurt which lowers cholesterolaemia in man, Atherosclerosis, 26:335-240. PereiraDIA, Gibson GR (2002). Effects of consumption of probiotics and prebiotics on serum lipid levels in humans, Critical Reviews in Biochemistry and Molecular Biology, 37: 259-281 QuanS, Tsuda H, Miyamoto T (2008). Angiotensin I-converting enzyme inhibitory peptides in skim milk fermented with Lactobacillus helveticus 130B4 from camel milk in Inner Mongolia, China. Journal of the Science of Food and Agriculture, 88:2688-2692 RaoDR, Chawan CB, Pulusani SR (1981). Influence of milk and thermophilus milk on plasma cholesterol levels and hepatic cholesterogenesis in rates. Journal of Food Science, 46: 1339 – 1341 . Reddy BS, MastromariniA, WynderE (1977). Diet and metabolism: large bowel cancer. Cancer, 39: 1815-1819 SAS(Statistical Analysis Systems),1990.User Guide Statistics. Version 6.0. SAS Inst.Inc., Cary. NC. Sboui, A, M Djegham, T Khorchani, M HammadiBarhoumi, O Belhadj (2010). Effect of Camel Milk on Blood Glucose, Cholesterol and Total Proteins Variations in Alloxan-Induced Diabetic Dogs. International Journal of Diabetes and Metabolism, 18: 5-11

SchaarmannG,JSchneider,AZom, CVilser, G Jahreis (2001). Influence of probiotic yoghurt on serum lipids in women. Am. J.Clin. Nutr., 73:4965. SeeligA, Seelig J (1996). Interaction of drugs and peptides with the lipid membrane, In T. Schwartz, S. A. Hijorth, & J. SandolmKastrup (Eds.), Alfred Benzon Symposium 39: Structure and function of 7Tm receptors (pp. 184-193). Copenhagen: Muntsgaard. ShalashMR (1984). The production and utilization of camel milk,InW. R. Cockrill (Ed.), The Camelid: An all-purpose animal (pp. 196-208). Uppsala, Sweden: Scandinavian Institute of African Studies. SuzukiY,HKaizu, YYamauchi (1991). Effect of cultured milk on serum cholesterol concentrations in rats fed high-cholesterol diets. Anim.Sci.Technol, 62:565-571. TahriK, Crociani J, BallongueJ, SchneiderF (1995). Effects of three strains of bifidobacteria on cholesterol, Letters in Applied Microbiology, 21:149-151. TrinderP (1969).Determination of total cholesterol, High density lipoprotesincholesterol and miglyceride by enzymatic colourimetric method, J. Clin. Pathol.,22:158.